Patents by Inventor Niels Ryde

Niels Ryde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GAMMA RADIATION STERILIZED NANOPARTICULATE DOCETAXEL COMPOSITIONS AND METHODS OF MAKING SAME
    Publication number: 20080220074
    Abstract: Nanoparticulate compositions comprising docetaxel or a salt, derivative, conjugate or analogue thereof, wherein the compositions are terminally sterilized via gamma radiation, are described, as well as methods of making and using such compositions.
    Type: Application
    Filed: March 20, 2008
    Publication date: September 11, 2008
    Applicant: ELAN CORPORATION PLC
    Inventors: H. William Bosch, Janine Keller, Niels Ryde
  • Low viscosity liquid dosage forms
    Publication number: 20080152585
    Abstract: The present invention relates to liquid dosage forms of nanoparticulate active agents having very low viscosities.
    Type: Application
    Filed: October 31, 2007
    Publication date: June 26, 2008
    Inventors: Tuula Ryde, Niels Ryde, H. William Bosch, John D. Pruitt, Christian F. Wertz
  • METHODS OF MAKING NANOPARTICULATE DRUG COMPOSITIONS COMPRISING COPOLYMERS OF VINYL PYRROLIDONE AND VINYL ACETATE AS SURFACE STABILIZERS
    Publication number: 20070141159
    Abstract: The present invention is directed to nanoparticulate compositions comprising a poorly soluble drug and at least one copolymer of vinyl pyrrolidone and vinyl acetate as a surface stabilizer adsorbed to the surface of the drug. Also encompassed by the invention are pharmaceutical compositions comprising a nanoparticulate composition of the invention, methods of making and using such nanoparticulate and pharmaceutical compositions.
    Type: Application
    Filed: August 30, 2005
    Publication date: June 21, 2007
    Inventors: H. Bosch, Niels Ryde
  • In vitro methods for evaluating the in vivo effectivness of dosage forms of microparticulate or nanoparticulate active agent compositions
    Publication number: 20070110776
    Abstract: Disclosed are in vitro methods for evaluating the in vivo redispersibility of dosage forms of poorly water-soluble active agents. The methods utilize media representative of in vivo human physiological conditions.
    Type: Application
    Filed: January 8, 2007
    Publication date: May 17, 2007
    Inventors: Eugene Cooper, John Bullock, John Chippari, John Schaefer, Rakesh Patel, Rajeev Jain, Joost Strasters, Niels Ryde, Stephen Ruddy
  • Novel glipizide compositions
    Publication number: 20050019412
    Abstract: The present invention is directed to nanoparticulate compositions comprising glipizide. The glipizide particles of the composition preferably have an effective average particle size of less than about 2 microns.
    Type: Application
    Filed: November 5, 2003
    Publication date: January 27, 2005
    Inventors: H. Bosch, Niels Ryde
  • Low viscosity liquid dosage forms
    Publication number: 20040105889
    Abstract: The present invention relates to liquid dosage forms of nanoparticulate active agents having very low viscosities.
    Type: Application
    Filed: April 23, 2003
    Publication date: June 3, 2004
    Applicant: Elan Pharma International Limited
    Inventors: Tuula Ryde, Niels Ryde, H. William Bosch, John D. Pruitt, Christian F. Wertz